As a Black ophthalmologist specializing in retinal diseases, I’ve witnessed firsthand the disproportionate impact of diabetic retinopathy on Black communities in the United States. Despite…
As a registered dietitian and nutrition expert with a focus on cultural competence, I’ve observed the significant impact of GLP-1 medications on weight loss and…
Free CME/CE Incentive provided The University of Florida and The Leukemia & Lymphoma Society are seeking participants for a compensated research study where primary care…
Yet another study supports the idea that the blockbuster GLP-1 drug Ozempic can help problem drinkers curb their intake, raising important questions about its potential…
Diabetes mellitus is a common cardiometabolic disease in the United States, and it can be influenced by many causes, including genetics and lifestyle. Diabetes is…
A recent study published in the Annals of Surgery Open revealed disparities in access to weight-loss surgery among Black patients. While Black individuals are just…
The National Minority Quality Forum recently hosted a critical discussion with BDO on the importance of Medicare coverage for obesity management medications. This timely conversation…
Healthcare professionals, play a crucial role in addressing the disparities in kidney donation and transplantation among Black patients. A conversation between doctors and donors provided…
Racial and ethnic disparities are seen in the use of obesity-management medications, according to a study published online Dec. 17 in the Journal of Racial…
Three of four patients stop taking Ozempic or Wegovy two years after being prescribed the blockbuster drugs for weight loss, a new analysis shows. Conducted…